Skip to main content
. 2016 Sep 27;9:301–304. doi: 10.2147/IMCRJ.S117731

Figure 1.

Figure 1

Changes in right visual acuity and frequency of ocular attacks during treatment.

Notes: Visual acuity remained at 1.0, and no ocular attacks occurred after switching to adalimumab. Black arrowheads indicate the timing of ocular attacks. *The frequency of attacks was converted into an annual frequency. Data in parentheses indicates the actual frequency of attacks during representative treatments.